| Celecoxib | 4-Hydrazinobenzene-1-sulfonamide Hydrochloride | 17852-52-7 |
| Tofacitinib | N-(4-Methyl-3-pyridinyl)acetamide | 52090-68-3 |
| Tofacitinib intermediate | N-(4-Methyl-3-pyridinyl)acetamide, Acetate (1:1) | 1789706-33-7 |
| Tofacitinib | 3-(Acetylamino)-4-methyl-1-(phenylmethyl)pyridinium Chloride (1:1) | 1638499-35-0 |
| Tofacitinib | N-[1,2,5,6-Tetrahydro-4-methyl-1-(phenylmethyl)-3-pyridinyl]acetamide | 1638499-36-1 |
| Tofacitinib | N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-Pyrrolo[2,3-d]pyrimidin-4-amine | 477600-74-1 |
| Tofacitinib | Tofacitinib API | 477600-75-2 |
| Tofacitinib | Tofacitinib Citrate | 40737-29-9 |
| Tofacitinib | p-Toluenesulfonic chloride | 98-59-9 |
| Upadacitinib | Carbamic acid N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2 3-b]pyrazin-2-yl]- ethyl ester | 1869118-24-0 |
| Upadacitinib | (3R 4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt | 2095311-49-0 |
| Upadacitinib | tert-butyl 5-tosyl-5H-pyrrolo[2 3-b]pyrazin-2-ylcarbamate | 1201187-44-1 |
| Upadacitinib | N-Tosyl-5-bromo-4 7-diazaindole | 1201186-54-0 |
| Upadacitinib | (3R 4S)-Benzyl 3-(2-(dimethylhydrosulfinylidene)acetyl)-4-ethylpyrrolidine-1-carboxylate | 2095311-50-3 |
| Upadacitinib | Upadacitinib free base | 1310726-60-3 |
![N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-Pyrrolo[2,3-d]pyrimidin-4-amine](http://rjrorwxhqioqli5p.ldycdn.com/static/assets/images/lazyloading.png?1695814009791)
![N-[1,2,5,6-Tetrahydro-4-methyl-1-(phenylmethyl)-3-pyridinyl]acetamide](http://ikrorwxhqioqli5p.ldycdn.com/static/assets/images/lazyloading.png?1695814009791)
